Plus, online GLP-1 prescription options have made the prescription process much more straightforward
The two most common agents include subcutaneous semaglutide (Ozempic, approved for type 2 diabetes, and Wegovy, approved for weight loss) and liraglutide (Saxenda, approved for weight loss, and Victoza, approved for type 2 diabetes), though an oral formulation of semaglutide is available (Rybelsus)
Payer Action Plan Monitor the Drug Pipeline: At this time, there is no action that payers need to take
SEEA Box 10.1 A1
Only in extremely high-dose, intravenous skin-whitening treatments has a temporary lightening of hair been reported as a potential side effect
Timing strategies: consider morning doses for daily energy support or pre-training intake for targeted performance enhancement